Simmiparib

simmiparib · Shanghai Acebright Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Simmiparib, covering 2017-01-05 to 2017-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Simmiparib in Patients With Malignant Advanced Solid Tumor [Phase 1]